You are here

Front > Search FHI 360

Search FHI 360

Start a New Search

Search within these results

HIV and AIDSClinical trials design and implementation

16 Results Found

  • Practice Area

    Health

    For FHI 360, improving the health of the world's women, men and children is core to our mission.
  • Feature

    China Tuberculosis Clinical Trials Consortium will advance global TB knowledge

    FHI 360 began the China Tuberculosis Clinical Trials Consortium to develop a TB clinical trials research platform that meets international standards and is able to enroll participants in global, multicenter studies.
  • News

    ECHO Study of hormonal contraception and HIV begins

    FHI 360 and partners embark on a landmark study designed to fill a critical gap in the scientific evidence on the relationship between HIV acquisition and hormonal contraceptives.
  • Published research

    Optimizing HIV prevention for women: A review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction

    Gender-related norms and inequalities that place women and girls at risk of acquiring HIV are also likely to affect their ability to use microbicides. Published vaginal microbicide studies were reviewed to identify gender-related factors that are likely to affect microbicide acceptability, access and adherence. This paper makes recommendations on product design, trial implementation, positioning, marketing and delivery of microbicides in a way that takes into account the gender-related norms and inequalities identified in the review.
  • Past Project

    Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center

    FHI 360 leads the Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center (RICC), which manages worldwide research teams.
  • Published research

    The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills

    Self-reported adherence in the FEM-PrEP study was high, yet in blood tests, drug concentrations revealed limited pill use. Participants primarily overreported adherence out of concern they would be terminated from FEM-PrEP for nonadherence and lose the study's health care benefits. Findings suggest women want access to better health care. Efforts to improve self-reporting should identify alternative methods for creating supportive environments for reporting actual adherence. 
  • Published research

    Pregnancy and contraceptive use among women participating in the FEM-PrEP trial

    Pregnancy among participants in HIV prevention clinical trials continues to present a challenge. This study found that women who adopted an injectable contraceptive at the beginning of the trial were more likely to adhere to study product than women using combined oral contraceptives. HIV prevention trials should consider requiring long-acting methods, including injectables, for study participation.
  • Past Project

    China Tuberculosis Clinical Trials Consortium (CTCTC) project

    FHI 360’s China Tuberculosis Clinical Trials Consortium provides mentoring and advice on the critical aspects of maintaining a successful tuberculosis clinical trial network in China.
  • Published research

    Lessons learnt from implementing an empirically informed recruitment approach for FEM-PrEP, a large HIV prevention clinical trial

    This paper describes the entire recruitment approach used in the FEM-PrEP clinical trial, starting with data collected during the preparedness phase, how those data were used to inform the recruitment strategies, changes incorporated throughout the clinical trial and lessons learned. 
  • News

    Study identifies ways to increase HIV testing, reduce HIV infection and detect previously undiagnosed HIV infections

    Study results presented today at the Conference on Retroviruses and Opportunistic Infections by the HIV Prevention Trials Network (HPTN) and the National Institutes of Health (NIH) show that a series of community efforts can increase the number of...